TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Wall Street NYSE Lead
Play
JIM CRAMER

Game Plan: Cramer's 'Mad Money' Recap (Friday 9/11/20)

  • By Scott Rutt
  • Sep 11, 2020 8:19 PM EDT
PRESS RELEASES

Horizon Therapeutics Plc Provides $1 Million In Scholarships To Help Economically Disadvantaged Students And Students Of Color Further Their Liberal Arts And Health Professions Education

  • By Business Wire
  • Dec 3, 2020 9:00 AM EST
PRESS RELEASES

Great Place To Work Names Horizon Therapeutics Plc To Best Workplaces For Parents List

  • By Business Wire
  • Dec 2, 2020 9:15 AM EST
PRESS RELEASES

Horizon Therapeutics Plc Donates Additional $1.2 Million To Support COVID-19 Relief Efforts In Illinois And Other Impacted U.S. And International Communities

  • By Business Wire
  • Nov 30, 2020 8:00 AM EST
PRESS RELEASES

Horizon Therapeutics Plc To Participate In Upcoming Investor Conferences

  • By Business Wire
  • Nov 25, 2020 8:00 AM EST
PRESS RELEASES

Horizon Therapeutics Plc And Halozyme Therapeutics, Inc. Enter Global Collaboration And License Agreement For ENHANZE® Technology

  • By Business Wire
  • Nov 23, 2020 8:00 AM EST
PRESS RELEASES

Horizon Therapeutics Plc And Halozyme Therapeutics, Inc. Enter Global Collaboration And License Agreement For ENHANZE® Technology

  • By PR Newswire
  • Nov 23, 2020 8:00 AM EST
PRESS RELEASES

First Thyroid Eye Disease (TED) Awareness Week To Increase Education And Understanding Of Vision-Threatening Disease

  • By Business Wire
  • Nov 16, 2020 8:00 AM EST
PRESS RELEASES

New Data Build On Growing Evidence Supporting TEPEZZA® (teprotumumab-trbw) Efficacy In Thyroid Eye Disease (TED), Including In Patients With Less Severe Disease And Longer Disease Duration

  • By Business Wire
  • Nov 13, 2020 8:30 AM EST
PRESS RELEASES

Horizon Therapeutics Plc CEO Tim Walbert Honored With RARE Champion Award At Global Genes Champions Of Hope Gala

  • By Business Wire
  • Nov 13, 2020 8:00 AM EST
PRESS RELEASES

Horizon Therapeutics Plc To Participate In Upcoming Investor Conferences

  • By Business Wire
  • Nov 12, 2020 8:00 AM EST
PRESS RELEASES

Higher Response Rates In RECIPE Randomized Controlled Trial Of KRYSTEXXA® (pegloticase Injection) Concomitantly Used With The Immunomodulator Mycophenolate Mofetil

  • By Business Wire
  • Nov 2, 2020 2:00 PM EST
PRESS RELEASES

Karin Rosén, M.D., Ph.D. (Photo: Business Wire)

  • By Business Wire
  • Nov 2, 2020 6:58 AM EST
PRESS RELEASES

Chicago Tribune Names Horizon Therapeutics A 2020 Top Workplace For The Sixth Consecutive Year

  • By Business Wire
  • Oct 30, 2020 9:15 AM EDT
PRESS RELEASES

New TEPEZZA® (teprotumumab-trbw) Data To Be Presented At The American Academy Of Ophthalmology 2020 Annual Meeting

  • By Business Wire
  • Oct 30, 2020 8:00 AM EDT
PRESS RELEASES

AGC Biologics And Horizon Therapeutics Plc Expand Partnership

  • By PR Newswire
  • Oct 29, 2020 3:00 PM EDT
PRESS RELEASES

Horizon Therapeutics Plc Initiates Clinical Trial To Assess Shorter Infusion Duration For KRYSTEXXA® (pegloticase Injection) Concomitantly Used With Methotrexate To Treat Uncontrolled Gout

  • By Business Wire
  • Oct 29, 2020 8:00 AM EDT
PRESS RELEASES

Horizon Therapeutics Plc Named One Of The Most Innovative Companies By Crain's Chicago Business

  • By Business Wire
  • Oct 26, 2020 8:00 AM EDT
PRESS RELEASES

Horizon Therapeutics Plc Named One Of The Best Adoption-Friendly Workplaces By The Dave Thomas Foundation For Adoption

  • By Business Wire
  • Oct 23, 2020 8:00 AM EDT
PRESS RELEASES

New Data Offers Insights On Treatment With KRYSTEXXA® (pegloticase Injection) Among Kidney Transplant Patients For The Management Of Uncontrolled Gout

  • By Business Wire
  • Oct 22, 2020 10:00 AM EDT
PRESS RELEASES

Horizon Therapeutics Plc Announces TEPEZZA® (teprotumumab-trbw) Selected As A Winner Of The Chicago Innovation Award

  • By Business Wire
  • Oct 20, 2020 8:00 AM EDT
PRESS RELEASES

FORTUNE And Great Place To Work® Name Horizon Therapeutics Plc To Best Medium Workplaces List For Fifth Consecutive Year

  • By Business Wire
  • Oct 16, 2020 8:30 AM EDT
PRESS RELEASES

TEPEZZA® (teprotumumab-trbw) Data From The Phase 2 Clinical Trial Evaluate Longer-Term Responses In People Living With Thyroid Eye Disease (TED)

  • By Business Wire
  • Oct 14, 2020 8:00 AM EDT
PRESS RELEASES

New Data Evaluating KRYSTEXXA® (pegloticase Injection) With Concomitant Immunomodulation To Be Presented At The American College Of Rheumatology Convergence 2020

  • By Business Wire
  • Oct 8, 2020 8:15 AM EDT
PRESS RELEASES

Horizon Therapeutics Plc To Release Third-Quarter 2020 Financial Results And Host Webcast On Nov. 2, 2020

  • By Business Wire
  • Oct 8, 2020 8:00 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.